Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · IEX Real-Time Price · USD
0.403
-0.006 (-1.49%)
At close: Jul 19, 2024, 4:00 PM
0.416
+0.012 (3.03%)
Pre-market: Jul 22, 2024, 9:12 AM EDT
Applied DNA Sciences Employees
As of September 30, 2023, Applied DNA Sciences had 55 total employees, including 52 full-time and 3 part-time employees. The number of employees decreased by 14 or -20.29% compared to the previous year.
Employees
55
Change (1Y)
-14
Growth (1Y)
-20.29%
Revenue / Employee
$100,325
Profits / Employee
-$227,285
Market Cap
3.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
Xylo Technologies | 84 |
Fresh2 Group | 75 |
Avinger | 72 |
Aptevo Therapeutics | 40 |
Scinai Immunotherapeutics | 31 |
Bio-Path Holdings | 10 |
Enveric Biosciences | 7 |
APDN News
- 3 days ago - U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract - Accesswire
- 4 weeks ago - Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics - Accesswire
- 4 weeks ago - Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing - Accesswire
- 5 weeks ago - Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health - Accesswire
- 5 weeks ago - Time to Play 5 Top-Ranked Stocks With Rising P/E? - Benzinga
- 6 weeks ago - Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform - Accesswire
- 2 months ago - Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML - Accesswire
- 2 months ago - Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results - Accesswire